Log in
Enquire now
‌

US Patent 10537453 Intragastric device with expandable portions

Patent 10537453 was granted and assigned to Obalon Therapeutics on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Obalon Therapeutics
Obalon Therapeutics
Current Assignee
Obalon Therapeutics
Obalon Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10537453
Patent Inventor Names
Daniel J. Proctor0
Betty Wong0
Eleanor McCarthy0
Kate Sapp0
Mark C. Brister0
Neil R. Drake0
Sheldon Nelson0
Date of Patent
January 21, 2020
Patent Application Number
15335256
Date Filed
October 26, 2016
Patent Citations Received
‌
US Patent 12102547 Intragastric volume-occupying device and method for fabricating same
0
‌
US Patent 11779482 Intragastric device
‌
US Patent 12090075 Intragastric device
0
‌
US Patent 11974934 Intragastric device
0
Patent Primary Examiner
‌
Ryan J. Severson
Patent abstract

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10537453 Intragastric device with expandable portions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.